Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung

Journal of Nuclear Medicine

Volumn 38, Issue 3, 1997, Pages 391-395

  Stein, Rhona ^a   Goldenberg, David M ^b   Thorpe, Suzanne R ^b   Mattes, M Jules ^b  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b NONE

Author keywords

Dilactitol tyramine; Lung cancer xenograft; Monoclonal antibodies; Radioiodine; Residualizing radiolabels

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY I 131; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; DOSE CALCULATION; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; TYRAMINE;

EID: 0030883054     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goldenberg DM. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Semin Nucl Med 1989;19:332-339.
2. Kyriakos RJ, Shih LB, Ong GL, Patel K, Goldenberg DM, Mattes MJ. The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res 1992;52:835-842.
3. Mattes MJ, Griffiths GL, Diril H, Goldenberg DM, Ong GL, Shih LB. Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells. Cancer 1994;73:787-793.
4. Geissler F, Anderson SK, Venkatesan P, Press O. Intracellular catabolism of radiolabeled anti-μ antibodies by malignant B-cells. Cancer Res 1992;52:2907-2915.
5. Vaes G. Digestive capacity of lysosomes. In: Hers HG, Van Hoof F, eds. Lysosomes and storage diseases. New York: Academic Press; 1973:43-77.
6. LaBadie JH, Chapman KP, Aronson NN, Jr. Glycoprotein catabolism in rat liver. Lysosomal digestion of iodinated asialo-fetuin. Biochem J 1975;152:271-279.
7. Harapanhalli RS, Schafranek W, Ong GL, Mattes MJ. Lysine-directed radioiodination of proteins with a cyanuric chloride derivative of aminofluorescein. Analytical Biochem 1995;231:50-56.
8. Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 1989;49: 4906-4912.
9. Hanna R, Ong GL, Mattes MJ. Processing of antibodies bound to B-cell lymphomas and other hematological malignancies. Cancer Res 1996;56:3062-3068.
10. Thorpe SR, Baynes JW, Chroneos ZC. The design and application of residualizing labels for studies on protein catabolism. FASEB J 1993;7:399-405.
11. Motta-Hennessy C, Sharkey RM, Goldenberg DM. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J Nucl Med 1990;31:1510-1519.
12. Shih LB, Thorpe SR, Griffiths GL, et al. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. J Nucl Med 1994;35:899-908.
13. Zalutsky MR, Noska MA, Colapinto EV, Garg PK, Bigner DD. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate. Cancer Res 1989;49:5543-5549.
14. Wilbur DS, Hadley SW, Hylarides MD, et al. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J Nucl Med 1989;30:216-226.
15. Ali SA, Warren SD, Richter KY, et al. Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts. Cancer Res 1990;50:(suppl):783s-788s.
16. Stein R, Goldenberg DM, Thorpe SR, Mattes MJ. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res 1995;55:3132-3139.
17. Reist CJ, Archer GE, Kurpad SN, et al. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res 1995;55:4375-4382.
18. Stein R, Basu A, Chen S, Shih LB, Goldenberg DM. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Int J Cancer 1993;55:1-9.
19. De Leij L, Helfrich W, Stein R, Mattes MJ. SCLC-Cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int J Cancer 1994;8:(suppl):60-63.
20. Huet C, Ash JF, Singer SJ. The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblasts. Cell 1980;21:429-438.
21. Stein R, Chen S, Sharkey RM, Goldenberg DM. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting. Cancer Res 1990;50:1330-1336.
22. Siegel JA, Stabin MG. Absorbed fractions for electrons and beta particles in small spheres [Abstract]. J Nucl Med 1988;29:803.
23. Ong GL, Mattes MJ. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res 1989;49:4264-4273.
24. Fenwick JR, Philpott GW, Connett JM. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake. Int J Cancer 1989;44:1017-1027.
25. Blumenthal RD, Fand I, Sharkey RM, Boerman OC, Kashi R, Goldenberg DM. The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. Cancer Immunol Immunother 1991;33:351-358.
26. Juweid M, Neumann R, Paik C, et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 1992;52:5144-5153.
27. 2 in nude mice bearing human tumor xenografts. Cancer 1994;73:816-823.
28. 131I-labeled monoclonal antibody RS7-3G11. Antibody Immmoconj Radiopharm 1991;4:703-712.
29. 177Lu-labeled immunoconjugate. Cancer Res 1991;51:2889-2896.
30. Strobel JL, Baynes JW, Thorpe SR. Iodine-125-glycoconjugate labels for identifying sites of protein catabolism in vivo: effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation. Arch Biochem Biophys 1985;240:635-645.